Search the courses, subjects, tracks, games and features, or jump straight to a page.
Gene therapy is utilized to rectify or substitute faulty genes in patients, employing innovative methods such as viral and non-viral delivery systems to ensure successful treatment. The chapter emphasizes the approval of several gene therapies for clinical use and addresses the essential ethical, safety, and regulatory issues that accompany this rapidly advancing field. With a focus on personalized approaches and the integration of AI in gene therapy, the future possibilities are promising.
Chapter 327 sections
Gene therapy is utilized to rectify or substitute faulty genes in patients, employing innovative methods such as viral and non-viral delivery systems to ensure successful treatment. The chapter emphasizes the approval of several gene therapies for clinical use and addresses the essential ethical, safety, and regulatory issues that accompany this rapidly advancing field. With a focus on personalized approaches and the integration of AI in gene therapy, the future possibilities are promising.
Gene therapy aims to correct or replace defective genes in patients.
Viral and non-viral delivery systems are critical to therapy success.
Several gene therapies are now approved and in clinical use.
Ethical issues and safety are central to regulation and public acceptance.
Future applications include personalized and AI-optimized gene therapies.
The introduction of genetic material into a patient to treat or prevent disease.
A type of gene therapy that affects only the treated individual and is widely accepted.
A controversial form of gene therapy that alters genes in reproductive cells, thereby affecting future generations.
Modified viruses used to deliver genes into cells for therapeutic purposes, associated with long-term gene expression.
Cells are modified outside the body and then reintroduced, often used in CAR-T therapies for cancer.
Direct delivery of therapeutic genes to patients' bodies, commonly employed for muscular dystrophy and eye disorders.
Organizations responsible for the oversight of gene therapy practices, including the FDA, EMA, and ICMR.
Total Questions
2
Estimated Time
4 min
Passing Score
70%
1 more question available